Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 6,400 shares, a decrease of 34.0% from the May 15th total of 9,700 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average […]
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Wednesday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Up 2.4 % Shares of Diffusion Pharmaceuticals stock opened at $3.60 on Wednesday. The firm has a market cap of $7.34 million, […]
StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report issued on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.81 on Monday. The stock has a market cap of $7.77 million, a P/E ratio of -0.50 and a beta […]
StockNews.com initiated coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report released on Monday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.81 on Monday. The firm has a fifty day moving average price of $4.10 and a 200 day […]
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note published on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 1.4 % Diffusion Pharmaceuticals stock opened at $3.88 on Monday. The business has a 50-day simple moving average of $4.14 and a 200 […]